Kindred Biosciences, Inc. (KIN) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	11.6	16.0	56.3	34.8	6.7	20.0	13.0	65.3
Short-term investments	46.8	55.7	17.6	46.2	50.1	53.1	88.1
Accounts receivable, net	0.6	0.9	0.9
Inventories	0.2	4.2	3.6
Other current assets	3.4	2.5	1.7	0.8	1.3	0.7	0.5	0.1
Total current assets	62.6	79.3	80.1	81.8	58.0	73.8	101.5	65.5
Property, plant, and equipment, net	28.2	29.8	26.3	7.5	2.4	1.2	0.4	0.0
Long-term investments	1.5	1.8		1.5	1.1	4.6
Other fixed assets	0.1	0.1	0.1	0.0	0.0	0.0	0.0
Total assets	95.8	114.0	106.5	90.8	61.6	79.6	101.9	65.5

Accounts payable	0.1	1.3	3.6	1.4	0.4	0.7	0.4	0.7
Accrued expenses	2.7	4.8	8.2	3.0	1.9	2.0	1.5	0.9
Short-term debt	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Short-term debt	1.1
Other current liabilities	2.9	4.2	3.4	1.6	1.5	0.5	1.0	0.6
Total current liabilities	6.9	10.2	15.2	6.0	3.9	3.2	2.9	2.2
Long-term debt	38.1	19.3
Other liabilities	-16.7	2.6	0.1	0.1	0.0	0.0	0.0
Total liabilities	28.3	32.1	15.3	6.1	3.9	3.2	2.9	2.2

Shareholders' equity [+]	67.5	81.9	91.2	84.7	57.7	76.4	99.0	63.3
Paid-in capital	312.3	305.0	252.9	196.7	138.8	135.0	130.5	67.6
Retained earnings	-244.9	-223.1	-161.7	-112.0	-81.1	-58.6	-31.5
Tangible shareholders' equity	67.5	81.9	91.2	84.7	57.7	76.4	99.0	63.3